|
ALGS Aligos Therapeutics Inc 1799448 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,504,000.00 |
| Balance Sheet |
|
Current Assets
|
$62,127,000.00 |
|
Assets
|
$66,327,000.00 |
|
Current Liabilities
|
$28,343,000.00 |
|
Liabilities
|
$34,443,000.00 |
|
Equity
|
$31,884,000.00 |
|
Shares Out
|
6236828.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-48,078,000.00 |
|
Investing Cash Flow
|
$59,930,000.00 |
| Market Analysis |
Market Cap
|
$40,165,172.32 |
|
Price
|
$6.44 |
|
BVPS
|
5.11 |
|
PB
|
1.26 |
|
EPS
|
-0.14 |
|
PS
|
3.06 |
|
FCF
|
$-48,208,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:46 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-1.91 |
|
|
2026-05-07 |
-2.21 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.53 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-3.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALGS documents filed with the SEC.
ALGS Filings
Clear
